Tissue factor pathway inhibitor(Shire/3B)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameTissue factor pathway inhibitor(Shire/3B)
Drug Alias NameTissue factor pathway inhibitor(Baxalta/3B)Tissue factor pathway inhibitor(Baxter/3B)JBT-A7JBT-B5
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionFactor Xa inhibitorsCoagulation factor X inhibitorsTissue factor pathway inhibitor inhibitors +[4] 
TargetsTissue factor pathway inhibitorCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBaxter Innovations Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShireBaxter Innovations Gmbh3B Pharmaceuticals GmbH +[4] 
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A